Clinical studies specifically monitoring glucose metabolism through oral glucose tolerance tests found no significant changes in glucose handling, and fasting insulin levels remained stable throughout treatment periods lasting up to 24 weeks
The peptide functions through beta-3 adrenergic receptor activation in adipose tissue
Timing considerations AOD 9604 works best when injected in a fasted state
For instance, a study published in the New England Journal of Medicine reported that Liraglutide, a GLP-1 receptor agonist, led to substantial weight loss and improvements in glycaemic control in obese patients with type 2 diabetes
Taking a pill takes seconds, you can do it anywhere, and there are no needles, which matters for anyone with a needle phobia
No claims are made regarding therapeutic, diagnostic, or biological suitability beyond research use